<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>10425620</identifier>
<setSpec>0025-7753</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Julian, J F</dc:author>
<dc:author>Alastrué, A</dc:author>
<dc:author>Castellà, E</dc:author>
<dc:author>Fraile, M</dc:author>
<dc:author>Barnadas, A</dc:author>
<dc:author>Rull, M</dc:author>
<dc:description xml:lang="en">BACKGROUND Sentinel-node biopsy is meant to excise the first-echelon node from a primary tumor, which is the one that most probably harbors early metastases. PATIENTS AND METHODS We report our results in 35 patients with breast cancer, using a radiotracer by peri-tumoral injection, pre-surgical scintigraphy and intraoperative mapping with a gamma probe. RESULTS The technical success rate was 97%, negative predictive value 95.2%, accuracy 97%, and added value to staging 40%. CONCLUSION Compared with the conventional lymph-node staging procedure for breast cancer, sentinel-node biopsy with pre-surgical scintigraphy seems a good practical choice.</dc:description>
<dc:type>Comparative Study</dc:type>
<dc:language>es</dc:language>
<dc:date>1999 Jun 19 </dc:date>
<dc:title xml:lang="es">Biopsia selectiva del ganglio centinela en pacientes con cáncer de mama. Primeros resultados.</dc:title>
<dc:title xml:lang="en">[Selective biopsy of the sentinel ganglion in patients with breast cancer. Initial results].</dc:title>
<dc:publisher>Medicina clinica</dc:publisher>
</metadata>
</record>
</pubmed-document>
